Sildenafil Citrate
23 NDCs across 8 manufacturers|15 Generic,8 Brand
Sildenafil Citrate is used to treat pulmonary hypertension and vasculogenic impotence, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 27, 1998, and the first generic was approved Nov 6, 2012. FDA's Orange Book lists 73 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $46 million on Sildenafil Citrate across 839,000 claims for 241,000 beneficiaries.
Sildenafil Citrate is available as 23 NDCs from 8 manufacturers (15 generic, 8 brand), with NADAC prices from $0.11 to $84.57 per EA — the most expensive product costs about 800× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
23
15G / 8B
Manufacturers
8
competing in market
Price Spread
$0.11 – $84.57
per EA, 19 of 23 NDCs
7d Activity
avg -1.8% WoW · of 23 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
8 manufacturers producing SILDENAFIL CITRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VIAGRA 50 MG TABLET | $84.5695 per EA | — |
VIAGRA 50 MG TABLET | $84.5695 per EA | — |
VIAGRA 50 MG TABLET | $84.5695 per EA | — |
VIAGRA 100 MG TABLET | $83.6329 per EA | -0.09% |
VIAGRA 100 MG TABLET | $83.6329 per EA | -0.09% |
VIAGRA 100 MG TABLET | $83.6329 per EA | -0.09% |
VIAGRA 25 MG TABLET | $74.9876 per EA | — |
REVATIO 20 MG TABLET | $46.6786 per EA | — |
SILDENAFIL 10 MG/ML ORAL SUSP | $0.2727 per ML | -13.92% |
SILDENAFIL 10 MG/ML ORAL SUSP | $0.2727 per ML | -13.92% |
SILDENAFIL 10 MG/ML ORAL SUSP | $0.2727 per ML | -13.92% |
SILDENAFIL 10 MG/ML ORAL SUSP | $0.2727 per ML | -13.92% |
SILDENAFIL 100 MG TABLET | $0.1276 per EA | +1.26% |
SILDENAFIL 100 MG TABLET | $0.1276 per EA | +1.26% |
SILDENAFIL 100 MG TABLET | $0.1276 per EA | +1.26% |
SILDENAFIL 100 MG TABLET | $0.1276 per EA | +1.26% |
SILDENAFIL 25 MG TABLET | $0.1220 per EA | +1.91% |
SILDENAFIL 25 MG TABLET | $0.1220 per EA | +1.91% |
SILDENAFIL 50 MG TABLET | $0.1058 per EA | +2.96% |
SILDENAFIL 50 MG TABLET | $0.1058 per EA | +2.96% |
SILDENAFIL 50 MG TABLET | $0.1058 per EA | +2.96% |
SILDENAFIL 50 MG TABLET | $0.1058 per EA | +2.96% |
SILDENAFIL 50 MG TABLET | $0.1058 per EA | +2.96% |
Frequently Asked Questions
What is Sildenafil Citrate used to treat?
Sildenafil Citrate is used to treat pulmonary hypertension and vasculogenic impotence, per the National Library of Medicine's MED-RT classification.
When did Sildenafil Citrate become available as a generic?
FDA approved the first generic Sildenafil Citrate (ANDA) on Nov 6, 2012. The Orange Book currently lists 73 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Sildenafil Citrate?
In 2024, Medicare Part D spent $46 million on Sildenafil Citrate across 839,000 claims for 241,000 beneficiaries.
How many Sildenafil Citrate products are on the market?
The Sildenafil Citrate drug market contains 23 NDCs from 8 manufacturers — 15 generic and 8 brand products.
What is the price range for Sildenafil Citrate?
NADAC reference prices for Sildenafil Citrate range from $0.1058 to $84.5695 per EA — the most expensive product costs about 800× the cheapest. 4 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Sildenafil Citrate cheaper than brand?
The average generic NADAC for Sildenafil Citrate is $0.1167 per EA, versus $78.2842 for brand-labeled products — brand versions average about 671× the generic price.
Which manufacturers make Sildenafil Citrate?
8 manufacturers list Sildenafil Citrate in NADAC. Ranked by number of NDCs, the largest are Nivagen Pharmaceuticals Inc. (7), Pfizer Inc. (6), Mylan Pharmaceuticals Inc. (4), Viatris Specialty LLC (2), Zydus Pharmaceuticals (USA) Inc. (1).
How has the price of Sildenafil Citrate changed recently?
Over the past 7 days, 11 Sildenafil Citrate NDCs rose and 7 fell, with a market-wide average change of -1.8%.